A disruptive leap in non-contrast MR Angiography

Imaging Diabetics with MR

About 347 million people worldwide have diabetes.1 In many cases this leads to perihperal artery disease.

"The high prevalance of chronic renal impairment in diabetic patients with PAD and the need for high doses of gadolinium based contrast agents place them at risk for nephrogenic system fibrosis."2

QISS3 provides an accurate non-contrast alternative to CE-MRA for demonstrating clinically significant arterial disease in patients where contrast agents are contraindicated.2,4 Enhance clinical capabilities with access to latest clinical standards of care and improve patient safety with the reduced need for CE-MRA.

Siemens - MRI - QISS - Image - Customer Carr

"QISS MRA should become the non-contrast MRA technique of choice in patients with renal dysfunction."5

Maria Carr, Research Technologist
Northwestern University Feinberg School of Medicine
Chicago, US

Clinical Images

High Acceleration Quiescent-Interval Single Shot Magnetic Resonance Angiography at 1.5 and 3T

Non-Contrast-Enhanced ECG-Gated Quiescent Interval Single Shot MR Angiography of the Lower Extremities at 3 Tesla: a Case Report

Quiescent-Intervall Single-Shot Magnetic Resonance Angiography

QISS Non-Contrast MR Angiography: A study of Three Cases with Peripheral Vascular Disease

Peripheral arterial disease in patients with diabetes.

Quiescent-Interval Single-Shot Unenhanced Magnetic Resonance Angiography of Peripheral Vascular Disease: Technical Considerations and Clinical Feasibility

Peripheral arterial disease in a symptomatic diabetic population: prospective comparison of rapid unenhanced MR angiography (MRA) with contrast-enhanced MRA.

Evaluation of peripheral arterial disease with nonenhanced quiescent-interval single-shot MR angiography.

Nonenhanced ECG-gated quiescent-interval single-shot MRA (QISS-MRA) of the lower extremities: comparison with contrast-enhanced MRA.

Comparison of quiescent inflow single-shot and native space for nonenhanced peripheral MR angiography.

Nonenhanced peripheral MR-angiography (MRA) at 3 Tesla: evaluation of quiescent-interval single-shot MRA in patients undergoing digital subtraction angiography.

Evaluating Peripheral Arterial Disease With Unenhanced Quiescent-Interval Single-Shot MR Angiography at 3T

Nonenhanced ECG-Gated Quiescent-Interval Single Shot MRA: Image Quality and Stenosis Assessment at 3 Tesla Compared With Contrast-Enhanced MRA and Digital Subtraction Angiography

ECG-gated quiescent-interval single-shot MR angiography of the lower extremities: initial experience at 3 T.

Non-contrast-enhanced MR angiography at 3 Tesla in patients with advanced peripheral arterial occlusive disease.

Sequence comparison for non-enhanced MRA of the lower extremity arteries at 7 Tesla

1 Danaei-Lancet-378-31

2 Hodnett-AmJRoentgenol-197 (6)-1466

3 510(k) pending

4 Knobloch-ClinRadiol-69-4854

5 The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.

Did this information help you?
Thank you for your response
We detected numbers and/or an '@' symbol in your comment. Are you trying to enter a phone number or email address so that we may contact you, please contact us via our email form instead.

Note: to get a direct personal response, please contact us via our email form.

Thank you